epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Enbrel
    etanercept
  • remove Questran Light
    cholestyramine
  • remove Zylet
    loteprednol/ tobramycin ophthalmic

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Enbrel (etanercept) + Zylet (loteprednol/ tobramycin ophthalmic)

Caution Advised


etanercept + loteprednol ophthalmic

caution advised: combo may incr. risk of serious infection (additive effects)

Additional Considerations

Smiley face Smiley face cholestyramine in Questran Light

give oral drugs at least 1h before or 4-6h after cholestyramine; bile acid sequestrant may delay or decr. absorption of concomitant oral drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information